• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, INC VITEK® 2 AST-YS07 TEST KIT; VITEK® 2 AST-YS07 TEST CARD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, INC VITEK® 2 AST-YS07 TEST KIT; VITEK® 2 AST-YS07 TEST CARD Back to Search Results
Catalog Number 414967
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Patient Involvement (2645)
Event Type  malfunction  
Event Description
A customer from (b)(6) reported to biomérieux a false susceptible result for a candida glabrata external quality control sample, in association with the vitek® 2 ast-ys07 test kit.The customer twice tested the strain with ast-ys07 and obtained a result of fluconazole susceptible (mic=2) when the expected result was fluconazole resistant (mic=16-32).The strain was cultured on cos (columbia + sheep blood) media for 24 hours at 37°c.The customer reported the incorrect result was not reported to a physician and did not impact a patient results or treatment.The test reports were requested from the customer.A biomerieux investigation will be initiated.
 
Manufacturer Narrative
An internal investigation was conducted due to a report of false susceptible fluconazole (flu) for candida glabrata lab quality survey sample in association with the vitek® 2 ast-ys07 card.Organism identification was confirmed, and testing included two (2) random lots of vitek® 2 ast-ys07 cards from cba and chrom id candida 2 (can2) subcultures.Note: the customer's lot of ast-ys07 card was expired.Broth microdilution (bmd), the reference method for the fluconazole formulary "flu01n", obtained a result of mic = 4 mg/l (s).Vitek® 2 ast-ys07 obtained fluconazole mic = 2 mg/l (s) from cba subculture, and flu mic = 4 mg/l (s) from can2 subculture, with each random lot tested.The investigation reproduced the customer result.The vitek® 2 results (2 or 4) are in essential agreement, within 1 doubling dilution, with the reference mic (4 mg/l obtained with bmd), without category error.The investigation concluded the vitek® 2 ast-ys07 cards performed as intended.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITEK® 2 AST-YS07 TEST KIT
Type of Device
VITEK® 2 AST-YS07 TEST CARD
Manufacturer (Section D)
BIOMERIEUX, INC
595 anglum road
st. louis MO 63042
Manufacturer (Section G)
BIOMERIEUX, INC
595 anglum road
st. louis MO 63042
Manufacturer Contact
ellen weltmer
595 anglum road
st. louis, MO 63042
3147317301
MDR Report Key6281000
MDR Text Key65914195
Report Number1950204-2017-00033
Device Sequence Number1
Product Code NGZ
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K133817
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 07/11/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/26/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/23/2017
Device Catalogue Number414967
Device Lot Number287378322
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/16/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/23/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-